Finding a method of contraception that is both convenient and effective has been a challenge faced by women of reproductive age for many years. The hormonal contraceptive Depo-Provera® (depot medroxyprogesterone acetate, DMPA) has addressed this problem in recent years. However there are side effects that must be considered with any drug therapy, and one of the major concerns for women in the United States has been with the assumed or experienced weight gain associated with DMPA use. Early studies and product information report a gain anywhere from 4-6 pounds in the first year of use. This correlated to dissatisfaction with the product and discontinuation of DMPA as a birth control method. However, more recent evidence contradicts this rese...
Because of weight gain, women often discontinue hormonal contraception, especially depot medroxyprog...
BACKGROUND: Weight gain is commonly reported as a side effect of hormonal contraception and can lead...
The characteristics of 232 women using depot medroxyprogesterone acetate (DMPA) and of 675 women usi...
Abstract Depo-medroxyprogesterone acetate (DMPA) is an increasingly popular contraceptive choice amo...
Background: Depo Medroksi Progesterone Acetate (DMPA) is one method of contraception. Side effects o...
Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)Background: Weight gain is a frequent r...
To determine weight variation in women with different Body Mass Index (BMI) in use of trimestral inj...
Purpose: to determine weight variation in women with different Body Mass Index (BMI) in use of trime...
Objective—To examine if early weight gain in depot medroxyprogesterone acetate (DMPA) users predicts...
Background Progestin-only contraceptives (POCs) are appropriate for many women who cannot or should ...
UnrestrictedBackground: Subcutaneous depo-medroxyprogesterone acetate (DMPA-SC) has not been studied...
Background: Millions of women worldwide use depot medroxyprogesterone acetate (DMPA) for contra-cept...
ABSTRACT The Indonesian government has implemented family planning (FP) to reduce the rate of popula...
Background: Progesterone only injectable contraceptive provides long acting contraception against un...
Objectives Weight gain is a concern with the contraceptive depot-medroxyprogesterone acetate (DMPA);...
Because of weight gain, women often discontinue hormonal contraception, especially depot medroxyprog...
BACKGROUND: Weight gain is commonly reported as a side effect of hormonal contraception and can lead...
The characteristics of 232 women using depot medroxyprogesterone acetate (DMPA) and of 675 women usi...
Abstract Depo-medroxyprogesterone acetate (DMPA) is an increasingly popular contraceptive choice amo...
Background: Depo Medroksi Progesterone Acetate (DMPA) is one method of contraception. Side effects o...
Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)Background: Weight gain is a frequent r...
To determine weight variation in women with different Body Mass Index (BMI) in use of trimestral inj...
Purpose: to determine weight variation in women with different Body Mass Index (BMI) in use of trime...
Objective—To examine if early weight gain in depot medroxyprogesterone acetate (DMPA) users predicts...
Background Progestin-only contraceptives (POCs) are appropriate for many women who cannot or should ...
UnrestrictedBackground: Subcutaneous depo-medroxyprogesterone acetate (DMPA-SC) has not been studied...
Background: Millions of women worldwide use depot medroxyprogesterone acetate (DMPA) for contra-cept...
ABSTRACT The Indonesian government has implemented family planning (FP) to reduce the rate of popula...
Background: Progesterone only injectable contraceptive provides long acting contraception against un...
Objectives Weight gain is a concern with the contraceptive depot-medroxyprogesterone acetate (DMPA);...
Because of weight gain, women often discontinue hormonal contraception, especially depot medroxyprog...
BACKGROUND: Weight gain is commonly reported as a side effect of hormonal contraception and can lead...
The characteristics of 232 women using depot medroxyprogesterone acetate (DMPA) and of 675 women usi...